RxDoctor Payments Data

David Diffine, MD

Family Medicine · Blytheville, ARNPI 1679576631

Payments from drug & device makers

$1,524in general payments, 2019–2025

Across 107 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$814
  • GSK$230
  • Lilly USA, LLC$106
  • Sunovion Pharmaceuticals Inc.$101
  • AstraZeneca$54
  • Axsome Therapeutics, Inc.$46
  • plus $173 from 7 others

What the payments were for

  • Food & beverage$1,524100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,524 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$126,299
Medicare patients
191
Services billed
2,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$35,607
LinzessLinaclotide41$25,166
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen792$23,207
EliquisApixaban25$20,238
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,668
FarxigaDapagliflozin Propanediol16$10,570
XareltoRivaroxaban16$9,016
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,845
JanuviaSitagliptin Phosphate13$7,337
VyvanseLisdexamfetamine Dimesylate18$6,858
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$5,067
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen213$4,707
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$4,700
Gabapentin352$4,698
Humalog Kwikpen U-100Insulin Lispro12$3,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$814$25,16641 claims
AstraZenecaBreztri Aerosphere, Farxiga$54$21,23833 claims
PfizerEliquis$25$20,23825 claims
GSKTrelegy Ellipta$230$8,84514 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$22$6,85818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Blytheville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →